Abbisko Cayman Unit's Solid Tumor Drug Gets US FDA Approval for IND Application

MT Newswires12/03 13:21

和譽(02256.HK)附屬治療實體瘤抑制劑獲美國批准臨床試驗

AASTOCKS12/03 12:16

和誉-B(02256.HK)：创新PRMT5*MTA抑制剂ABSK131 IND申请获美国FDA批准

Gelonghui Finance12/03 12:11

Abbisko Doses First Gastric Cancer Patient in Phase II Study of Solid Tumor Drug

MT Newswires11/22 15:25

和誉-B(02256.HK)：口服PD-L1小分子抑制剂ABSK043联合FGFR2/3小分子抑制剂ABSK061治疗实体瘤的II期临床完成首例胃癌患者给药

Gelonghui Finance11/22 12:10

和誉-B(02256.HK)附属已完成ABSK061-201的首例胃癌患者给药

Finet News11/22 12:05